CARDIOCOMM SOLUTIONS SETS THE RECORD STRAIGHT; THE FIRST COMPANY TO RECEIVE APPROVAL FOR ECG PRODUCT SALES DIRECT TO CONSUMERS

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, firmly responds to recent technology companies’ announcements that it was the first company to be approved to sell an ECG product directly to consumers over the counter … Read more

CARDIOCOMM SOLUTIONS ANNOUNCES EXTENSION OF WARRANTS

by

–> TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, announced that it is seeking approval from the TSX Venture Exchange to extend the expiry dates of outstanding warrants exercisable to purchase an aggregate of 8,346,000 … Read more

CARDIOCOMM SOLUTIONS COMPLETES HEARTCHECK™ CLINICAL VALIDATION FOR LONG-TERM, SELF-MANAGED, REMOTE MONITORING OF ATRIAL FIBRILLATION PATIENTS POST-ABLATION

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms its HeartCheck™ device and GEMS™ software technologies have moved into routine clinical use following completion of a long-term, remote arrhythmia monitoring pilot in high risk patients. … Read more

CARDIOCOMM SOLUTIONS FDA 510K APPLICATION FOR NEWEST HEARTCHECK™ ECG DEVICE AND SMART PHONE APP ENTERS THE NEXT STAGE OF REVIEW

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, has received a request for additional information from the USA Food and Drug Administration (“FDA”) following the Company’s filing of its premarket notification 510(k), Class II medical … Read more

CARDIOCOMM SOLUTIONS ISSUES STOCK OPTIONS

by

–> TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, issued 62,500 stock options to Etienne Grima, the Company’s CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five … Read more

CARDIOCOMM SOLUTIONS FILES NEW FDA 510(K) APPLICATION FOR HOME AND TELEMEDICINE ARRHYTHMIA MONITORING SOLUTION

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms it has filed an application with the USA Food and Drug Administration (“FDA”) for premarket notification 510(k), Class II medical device clearance of the Company’s newest … Read more

CARDIOCOMM SOLUTIONS READIES FDA PREMARKET NOTIFICATION 510(K) APPLICATION FOR NEWEST HEARTCHECK OVER-THE-COUNTER HEART MONITORING SOLUTION

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, has initiated the application process to the USA Food and Drug Administration (“FDA”) for premarket notification 510(K), Class II medical device clearance of the Company’s newest consumer-based … Read more

CARDIOCOMM SOLUTIONS ADOPTS ADVANCE NOTICE POLICY

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) today announced that its board of directors has adopted an advance notice policy (the “Advance Notice Policy”). The purpose of the Advance Notice Policy is to provide shareholders, directors and management of the Company with direction on the procedure for shareholder nomination of … Read more

CARDIOCOMM SOLUTIONS TRADE MISSION TO JAPAN AND KOREA YIELDS 25 MEETINGS WITH TECHNOLOGY COMPANIES ON INTEGRATION, DISTRIBUTION AND CO-DEVELOPMENT OPPORTUNITIES

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) is pleased to announce that it held business meetings with 25 technology companies during an Ontario Trade Delegation visit to Japan and Korea from February 20 to 27. The meetings were arranged through the assistance of the Ontario Ministry of International Trade with … Read more

CARDIOCOMM SOLUTIONS PARTICIPATES IN ONTARIO TRADE MISSION TO JAPAN AND KOREA

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) is participating in a series of meetings organized by the Ontario Trade Commission in partnership with Global Affairs Canada which has led to a delegation visit to Japan and Korea from February 20th to 27th. Through the assistance of the Trade Commission, meetings … Read more